Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8723979 | Osteoporosis and Sarcopenia | 2018 | 7 Pages |
Abstract
These findings confirm the favorable safety and consistent effectiveness of ibandronate, and indicate that monthly IV ibandronate would be beneficial in daily practice for the treatment of Japanese patients with osteoporosis.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Yasuhiro Takeuchi, Junko Hashimoto, Yosuke Nishida, Chiemi Yamagiwa, Takashi Tamura, Akihide Atsumi,